Goldman Sachs initiates Stoke Therapeutics stock with buy rating on Dravet therapy potential

▶ Investing.com Jul 13, 2026 Jul 13 👁 4 views

📋 Article Summary

11 words

Read the full story on Investing.com via the link below.

ⓘ Summary only. Read the complete story on Investing.com below.

Full story on Investing.com

🔗 You will be taken to www.investing.com

► Necessary Cookies Always Active

Necessary cookies enable essential site features like secure log-ins and consent preference adjustments. They do not store personal data.

► Functional Cookies Remark

Functional cookies support features like content sharing on social media, collecting feedback, and enabling third-party tools.

► Analytical Cookies Remark

Analytical cookies track visitor interactions, providing insights on metrics like visitor count, bounce rate, and traffic sources.

► Advertisement Cookies Remark

Advertisement cookies deliver personalized ads based on your previous visits and analyze the effectiveness of ad campaigns.